News and updates

BMD_histology.jpg
 

ceo hanadie yousef’s nature paper featured in science signaling as editors choice

VCAM1-dependent inflammation in aged brain endothelial cells suppresses neurogenesis and cognitive performance.

 
 
 

Medium Blog Parameter mentions Juvena therapeutics

Investing in Anti-Aging and Longevity

 
 
 
 

CEO hanadie yousef’s Most Recent Publication in Nature Medicine

Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1.

 

JUVENA THERAPEUTICS MENTIONED IN Middle Market GrowtH

Innovation for an Aging Population

 

Juvena Therapeutics Mentioned in Forbes

 

Antibody can protect brains from the ageing effects of old blood

 
Copy of THE BLOODY BATTLE AGAINST AGING

The Berkeley science review

THE BLOODY BATTLE AGAINST AGING

 
Copy of THE MOLECULAR BASIS OF AGING

Hanadie Yousef, Cofounder and CEO, in SCOPE by Stanford Medicine

One researcher’s journey to understand the molecular basis of aging, using blood

 
Copy of DISCOVERED MOLECULE DRUG TO REVERSE AGING PROCESS

CEO highlighted in the daily californian

UC Berkeley researchers discover molecule drug that could reverse aging process

 
Copy of ENGINEERING THE END OF AGING

featured in vice: Engineering the End of Aging

A new drug that promises to stop muscles and brains from getting old.